Project Monitoring Group, DPIIT reviews 374 high impact infrastructure projects in FY 2021-22


Government of India has prioritized the timely completion of large-scale Infrastructure projects keeping infrastructure development as the central pillar of growth and socio-economic advancement of the country. With this vision in mind, the Project Monitoring Group (PMG) was instituted which is currently housed in Invest India, Ministry of Commerce and Industry.




PMG is a unique institutional mechanism to facilitate resolution of issues in infrastructure projects with investments upward of ₹ 500 crores primarily by way of conducting regular review meetings with States and Central Ministries. Additionally, with the deployment of milestone-based monitoring of projects on the PMG portal in November 2021, project reviews have become more holistic, combining both issue resolution and milestone-based monitoring to anticipate delays in projects, mitigating time and cost overruns and identifying agencies/authorities responsible for delays.




At present, PMG is monitoring 1,362 under implementation projects with total anticipated investment of approximately INR 47.55 lakh crore spanning across key sectors like Road, Transport and Highways, Railways, Petroleum and Natural Gas, New and Renewable Energy,  etc. Under the guidance of senior officers from DPIIT, in FY 2021-22, 787 new projects with an investment value of INR 19.6 lakh crore have been brought on PMG for monitoring. And 44 projects with an investment value of INR 1.25 lakh crore have been commissioned.




PMG has been convening regular review meetings between project proponents, State Governments and Union Ministries to accelerate project implementation through expeditious resolution of issues. Since April 2021, PMG has organized 30 review meetings with nearly all State Governments and Central Ministries. With the co-operation and active participation of the State Governments and Ministry Officials, 374 projects with a value of approximately INR 17 lakh crore have been reviewed during these meetings. As a result of regular reviews, 568 issues in 248 projects worth INR 12.20 lakh crores have been resolved.




Some marquee projects where pending issues have been resolved include: BharatNet, North East Gas Grid, Sivok Rangpo New Rail Line, and Jagdishpur – Haldia & Bokaro – Dhamra Pipeline Project (including Baruani Guwahati Pipeline Project).




For more information on PMG, kindly visit: pmg.dpiit.gov.in.


*****


AP/MS/PK




(Release ID: 1811562)
Visitor Counter : 216




Read this release in:



Hindi







Hong Kong – Update on monitoring COVID-19 vaccination

Update on monitoring COVID-19 vaccination

*****************************************


     In the preceding week till 11.59pm on January 30, the Department of Health (DH) received 92 reports (Note 1) of adverse events following COVID-19 immunisation. No death case was reported by the Hospital Authority (HA) involving individuals who had received vaccines within 14 days before they passed away and had potential association with vaccination.

      

     As at 8pm on January 30, around 11.12 million doses of COVID-19 vaccines had been administered for members of the public. Around 5.36 million people had received at least one dose of vaccine, accounting for 79.4 per cent of the population aged 12 or above. The DH received 6 885 reports (Note 1) of adverse events (0.06 per cent of the total vaccine doses administered). Among the death cases concerning persons who had been vaccinated, including 63 cases (Note 2) with vaccination within 14 days before they passed away (0.0006 per cent of the total vaccine doses administered), none of the death cases was associated with vaccination.

 

     As at January 30, the Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation had concluded that 38 death cases had no causal relationship with vaccination, and preliminarily considered that 15 cases were not associated with vaccination. Ten cases are still pending further information for assessment. The Expert Committee considered that there is no unusual pattern identified so far, and will continue to closely monitor the relevant situation and collect data for assessment.

 

     According to information from the HA, during the period from January 3 to January 30, the ratio of death cases out of those without a vaccination record was 166.0 cases for every 100 000 people, whereas the ratio of death cases for those with a vaccination record was 10.3 cases for every 100 000 people. The overall death rate is similar to that recorded in the past three years. Out of those without a vaccination record, the ratio of death cases with acute stroke or acute myocardial infarction was 8.2 cases for every 100 000 people, whereas the ratio of death cases under the same category for those with a vaccination record was 0.9 cases for every 100 000 people. Furthermore, the ratio of miscarriage cases out of those without a vaccination record was 40.0 cases for every 100 000 people, whereas the ratio of miscarriage cases for those who had a vaccination record was 11.0 cases for every 100 000 people. Based on the statistical analysis of the above figures, there is no evidence that vaccination increases the risk of death or miscarriage for recipients. The relevant reference statistics will be uploaded to the thematic website for the COVID-19 Vaccination Programme.

 

     The majority of non-death cases of adverse events received so far are relatively minor cases. The relevant details can be found in the “Report on the Safety Monitoring of COVID-19 Vaccines in Hong Kong” (www.drugoffice.gov.hk/eps/do/en/doc/Safety_Monitoring_of_COVID-19_Vaccines_in_Hong_Kong.pdf).

 

      “The COVID-19 vaccination rate for the elderly aged 80 or above in Hong Kong is only around 31 per cent at present, meaning that 69 per cent of the elderly in that age group are in a dangerous situation, which is alarming. The Comirnaty and CoronaVac vaccines are highly effective in preventing severe cases and deaths from COVID-19. They can provide effective protection to those vaccinated in preventing serious complications and even death after infection. The Government has expanded the third dose vaccination programme to include all people who have received two doses of vaccines for a period of time. We call on members of the public who are currently eligible for a third dose to get the dose as soon as possible. As for those not yet vaccinated, especially senior citizens, chronic patients and other immunocompromised persons who face a much higher chance of death after COVID-19 infection, they should get vaccinated as early as possible for better self-protection,” a Government spokesman said.

 

Note 1: Provisional figures. In the preceding week till 11.59pm on January 30, the DH did not receive any reports of suspected myocarditis or pericarditis involving adolescents aged 12 to 15.

 

Note 2: In the preceding week till 11.59pm on January 30, the DH received two death reports involving individuals who had received COVID-19 vaccination within 14 days before passing away. The cases involved two males aged 63 and 85 respectively. There is no clinical evidence that the incidents arose from vaccination.

Hong Kong – Update on monitoring COVID-19 vaccination

Update on monitoring COVID-19 vaccination

*****************************************


     In the preceding week till 11.59pm on October 31, the Department of Health (DH) received 30 reports (Note) of adverse events following COVID-19 immunisation. No death case was reported by the Hospital Authority (HA) involving individuals who had received vaccines within 14 days before they passed away and had potential association with vaccination.
      
     As at 8pm on October 31, around 9.04 million doses of COVID-19 vaccines had been administered for members of the public. Nearly 4.62 million people had received at least one dose of vaccine, accounting for 68.6 per cent of the population aged 12 or above. The DH received 6 280 reports (Note) of adverse events (0.07 per cent of the total vaccine doses administered). Among the death cases concerning persons who had been vaccinated, including 47 cases with vaccination within 14 days before they passed away (0.0005 per cent of the total vaccine doses administered), none of the death cases was associated with vaccination.
      
     As at today (November 3), the Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation had concluded that 29 death cases had no causal relationship with vaccination, and preliminarily considered that 18 cases were not associated with vaccination. The Expert Committee considered that there is no unusual pattern identified so far, and will continue to closely monitor the relevant situation and collect data for assessment.
      
     According to information from the HA, during the period from October 4 to October 31, the ratio of death cases out of those without a vaccination record was 116.5 cases for every 100 000 people, whereas the ratio of death cases for those with a vaccination record was 6.5 cases for every 100 000 people. The overall death rate is similar to that recorded in the past three years. Out of those without a vaccination record, the ratio of death cases with acute stroke or acute myocardial infarction was 5.8 cases for every 100 000 people, whereas the ratio of death cases under the same category for those with a vaccination record was 0.5 cases for every 100 000 people. Furthermore, the ratio of miscarriage cases out of those without a vaccination record was 30.2 cases for every 100 000 people, whereas the ratio of miscarriage cases for those who had a vaccination record was 11.7 cases for every 100 000 people. Based on the statistical analysis of the above figures, there is no evidence that vaccination increases the risk of death or miscarriage for recipients. The relevant reference statistics will be uploaded to the thematic website for the COVID-19 Vaccination Programme.
      
     The majority of non-death cases of adverse events received so far are relatively minor cases. The relevant details can be found in the “Report on the Safety Monitoring of COVID-19 Vaccines in Hong Kong” (www.drugoffice.gov.hk/eps/do/en/doc/Safety_Monitoring_of_COVID-19_Vaccines_in_Hong_Kong.pdf).
      
      “The Comirnaty and CoronaVac vaccines are highly effective in preventing severe cases and deaths from COVID-19. They can provide protection to those vaccinated to prevent serious complications and even deaths after infection. We appeal again to persons who are not yet vaccinated, especially senior citizens, chronic patients and other immunocompromised persons who face a higher chance of death after COVID-19 infection, to get vaccinated as soon as possible for better self-protection before the fifth wave strikes in Hong Kong,” a Government spokesman said.
 
Note: Provisional figures. In the preceding week till 11.59pm on October 31, the DH did not receive any reports of suspected myocarditis or pericarditis involving adolescents aged 12 to 15.

Hong Kong – Update on monitoring COVID-19 vaccination

Update on monitoring COVID-19 vaccination

*****************************************


     In the preceding week till 11.59pm on July 25, the Department of Health (DH) received 179 reports (Note 1) of adverse events following COVID-19 immunisation. No death case was reported by the Hospital Authority (HA) involving individuals who had received vaccines within 14 days before they passed away and had potential association with vaccination.

     As at 8pm on July 25, over 5.27 million doses of COVID-19 vaccines had been administered for members of the public. Around 3.03 million people had received at least one dose of vaccine, accounting for 44.6 per cent of the population aged 12 or above. The DH received 4 539 reports (Note 1) of adverse events (0.09 per cent of the total vaccine doses administered). Among the death cases concerning persons who had been vaccinated, including 27 cases (Note 2) with vaccination within 14 days before they passed away (0.0005 per cent of the total vaccine doses administered), none of the death cases was associated with vaccination.

     As at July 25, the Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation had concluded that 13 death cases had no causal relationship with vaccination, and preliminarily considered that 10 cases were not associated with vaccination. The four remaining cases were pending assessment. The Expert Committee considered that there is no unusual pattern identified so far, and will continue to closely monitor the relevant situation and collect data for assessment.

     According to information from the HA, during the period from June 28 to July 25, the ratio of death cases out of those without a vaccination record was 74.2 cases for every 100 000 people, whereas the ratio of death cases for those with a vaccination record was 2.3 cases for every 100 000 people. The overall death rate is similar to that recorded in the past three years. Out of those without a vaccination record, the ratio of death cases with acute stroke or acute myocardial infarction was 3.9 cases for every 100 000 people, whereas the ratio of death cases under the same category for those with a vaccination record was 0.2 cases for every 100 000 people. Furthermore, the ratio of miscarriage cases out of those without a vaccination record was 28.1 cases for every 100 000 people, whereas the ratio of miscarriage cases for those who had a vaccination record was 6.4 cases for every 100 000 people. Based on the statistical analysis of the above figures, there is no evidence that vaccination increases the risk of death or miscarriage for recipients. The relevant reference statistics will be uploaded to the thematic website for the COVID-19 Vaccination Programme.

     The majority of non-death cases of adverse events received so far are relatively minor cases. The relevant details can be found in the “Report on the Safety Monitoring of COVID-19 Vaccines in Hong Kong” (www.drugoffice.gov.hk/eps/do/en/doc/Safety_Monitoring_of_COVID-19_Vaccines_in_Hong_Kong.pdf).

Note 1: Provisional figures. During the same period, the DH received five reports of suspected myocarditis or pericarditis involving adolescents aged below 18 after receiving COVID-19 vaccination. The cases involved five males aged from 12 to 15. They experienced chest pains one to two days after receiving the Comirnaty vaccine. Their conditions are stable.
Note 2: In the preceding week till 11.59pm on July 25, the DH received a death report involving an individual who had received COVID-19 vaccination within 14 days before passing away. It involved a 74-year-old female who received the Sinovac COVID-19 vaccine. There is no clinical evidence that the incident arose from vaccination. The clinical cause of death is hypertensive heart disease.

Hong Kong – Update on monitoring COVID-19 vaccinations

Update on monitoring COVID-19 vaccinations

******************************************


     In the preceding week till 11.59pm on May 9, the Department of Health (DH) received 254 reports (Note 1) of adverse events following COVID-19 immunisation, including five death cases reported by the Hospital Authority (HA) involving individuals who had received COVID-19 vaccines.
      
     As at 8pm on May 9, about 1.74 million doses of COVID-19 vaccines had been administered for members of the public. Around 1.07 million people had received at least one dose of vaccine, accounting for 16.3 per cent of the population aged 16 or above. The DH received about 2 660 reports (Note 1) of adverse events (0.15 per cent of total vaccine doses administered), including 19 death cases with vaccinations within 14 days before they passed away (0.0011 per cent of total vaccine doses administered).
      
     As at May 9, the Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation (Expert Committee) (Note 2) concluded that seven death cases had no causal relationship with vaccinations, and preliminarily considered that 21 cases were not associated with vaccinations. Five cases were pending assessment. The Expert Committee considered that there is no unusual pattern identified so far, and will continue to closely monitor the relevant situation and collect data for assessment.
      
     According to information by the HA, during the period from April 5 to May 2, the ratio of death cases out of those without a vaccination record was 53.1 cases for every 100 000 people, whereas the ratio of death cases for those with a vaccination record was 2.3 cases for every 100 000 people. The overall death rate is similar to that recorded in the past three years. Out of those without a vaccination record, the ratio of death cases with acute stroke or acute myocardial infarction was 2.7 cases for every 100 000 people, whereas the ratio of death cases under the same category for those with a vaccination record was 0.4 cases for every 100 000 people. Based on the statistical analysis of the above figures, there is no evidence that vaccination increases the risk of death for recipients.
      
     The majority of non-death cases of adverse events received so far are relatively minor cases. The relevant details can be found at the “Report on the Safety Monitoring of COVID-19 Vaccines in Hong Kong” (www.drugoffice.gov.hk/eps/do/en/doc/Safety_Monitoring_of_COVID-19_Vaccines_in_Hong_Kong.pdf).
 
Note 1: Provisional figures
 
Note 2: The Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation perform continuous monitoring of the possible adverse events following administration of COVID-19 vaccines, and provide professional views and suggestions on safety monitoring of the authorised COVID-19 vaccines. The membership list and the key functions of the Expert Committee can be found at the following website (www.covidvaccine.gov.hk/en/expert).